Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0706790Aexternal-prioritypatent/GB0706790D0/en
Priority claimed from GB0714815Aexternal-prioritypatent/GB0714815D0/en
Priority claimed from PCT/GB2007/002908external-prioritypatent/WO2008015416A1/en
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Publication of AR062566A1publicationCriticalpatent/AR062566A1/en
Estos compuestos son utiles como inhibidores de la fosfodiesterasa de tipo IV (PDE4) y/o para tratamiento y/o profilaxis de enfermedades inflamatorias y/o alérgicas tales como enfermedad pulmonar obstructiva cronica (COPD), asma, o rinitis (por ejemplo rinitis alérgica y/o no alérgica).These compounds are useful as inhibitors of phosphodiesterase type IV (PDE4) and / or for treatment and / or prophylaxis of inflammatory and / or allergic diseases such as chronic obstructive pulmonary disease (COPD), asthma, or rhinitis (for example allergic rhinitis and / or non-allergic).
ARP070103813A2007-04-052007-08-28
PIRAZOLO COMPOUNDS (3,4-B] PIRIDINA, A PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITION
AR062566A1
(en)
COMPOUNDS DERIVED FROM ACID (3-AMINO-1,2,3,4-TETRAHIDRO-9H-CARBAZOL-9-IL) -ACETICO; PHARMACEUTICAL COMPOSITION; AND USE FOR THE PREVENTION AND / OR TREATMENT OF ALLERGIC AND IMMUNE DISEASES, SUCH AS ASTHMA, COPD AND RHINITIS AMONG OTHERS.
Compounds derived from heterocycles, antagonists for ccr2; and use of the compounds to treat respiratory tract conditions or diseases, such as chronic obstructive pulmonary disease and asthma.
COMPOUNDS DERIVED FROM REPLACED PIRROLIDINE, INHIBITORS OF PROTEASA ACTIVADORA DE CANAL; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF SUCH DISEASES AS CHYSTIC FIBROSIS, CHRONIC BRONCHITIS, COPD, ASTHMA AND VIAS R INFECTIONS
COMPOUNDS DERIVED FROM CHROMEN-2-ONA REPLACED; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF SUCH DISEASES AS ATEROSCLEROSIS, ASTHMA, ALLERGIC RHINITIS AND COPD.
COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF INFLAMMATORY OR OBSTRUCTIVE DISEASES OF THE RESPIRATORY ROADS, PULMONARY HYPERTENSION, PULMONARY FIBROSIS, FIBER
Compounds derived from a piperidinyl ester of biphenyl-2-ylcarbamic acid; pharmaceutical composition; pharmaceutical combination; and its use for bronchoconstriction, obstructive or inflammatory diseases of the respiratory tract.
Compounds derived from pyrazolo [3,4-b] pyridine carboxamide; pharmaceutical composition comprising them; and its use in the treatment of asthma, copd and rhinitis.
Compounds derived from pyrazole; pharmaceutical composition, method of preparation and; its use to treat a 5-lo-mediated disease such as asthma, bronchocontriction, emphysema, obstructive or inflammatory diseases of the airways, bronchitis, acute lung injury, bronchiectasis, allergic rhinitis, among others.
Compounds derived from 1-oxo-isoquinoline; preparation procedure; pharmaceutical composition; and its use in the treatment of chronic obstructive pulmonary diseases (COPD) and asthma.
Compounds derived from hydroxy-benzamides, muscarinic receptor antagonists; preparation procedure; intermediate compound; pharmaceutical composition; and use of the compound for the treatment of obstructive or inflammatory airway diseases, bronchoconstriction, asthma, bronchitis.
COMPOUNDS DERIVED FROM PIPERIDIL-PROPANO-TIOLES REPLACED, AGONISTS OR ANTAGONISTS OF CCR-3; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF ASTHMA AND ALLERGIC DISEASES, COPD, INFECTIONS BY PATHOGEN MICROBES, Rheumatoid ARTHRITIS AND AT